Projects funded by the NCN
The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution in patients with melanoma
2021/43/B/NZ7/01812
Keywords:
melanoma liquid biopsy next-generation sequencing resistance to therapy
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ2_2: Genomics, transcriptomics, epigenomics
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 11
Call: OPUS 22 - announced on 2021-09-15
Amount awarded: 1 414 772 PLN
Project start date (Y-m-d): 2022-07-18
Project end date (Y-m-d): 2026-07-17
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.